Concepedia

Karl‐Gustav Jostell

KJ

Statistics

Publications

3

Citations

92

H-Index

3

Active since

1990

Affiliations

AstraZeneca (Sweden)(Current)

Karl‐Gustav Jostell is an author at AstraZeneca (Sweden) specializing in medicine, pharmacology, and neuroscience.

Top concepts

MedicinePharmacologyNeurosciencePharmacotherapySocial SciencesNeuropharmacologyMolecular PharmacologySleepNeurologyPhysiology

Publications per year

1990–2012

3

Publications

3

AZD5213: a novel histamine H3 receptor antagonist permitting high daytime and low nocturnal H3 receptor occupancy, a PET study in human subjects

Aurelija Jučaitė, Akihiro Takano, Emma Boström et al. · The International Journal of Neuropsychopharmacology · 2012 · 53 citations

Sleep Disorders, Pharmacotherapy, Selective H3 Antagonist +23

Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke

Stig Strid, Charlotte Edenius, Karl‐Gustav Jostell et al. · European Journal of Clinical Pharmacology · 2002 · 27 citations

Pharmacological Study, Pharmacology, Pharmacological Agent +8

Selective dopamine D2 antagonist and prolactin response in acute schizophrenia — Results from remoxipride studies

A. George Awad, Y.D. Lapierre, Karl‐Gustav Jostell · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 1990 · 12 citations

Molecular Pharmacology, Psychiatry, Psychotic Disorder +11

1–3 of 3